A diagnostics firm has agreed to cease promoting two questionable blood checks as a part of a settlement with a client watchdog that accused the agency of utilizing “false and deceptive promoting” to advertise the merchandise.
Not solely was EpicGenetics claiming that one in every of its blood checks may definitively diagnose fibromyalgia, the Heart for Science within the Public Curiosity’s October 2023 lawsuit stated; the corporate had additionally invented a illness wholesale to justify using one other product, and had dangled nonexistent remedy trials as an enticement for sufferers.
EpicGenetics, its founder and CEO Bruce Gillis, and his different firms proceed to disclaim all wrongdoing, however they’ve agreed to cease advertising and marketing and promoting these two checks, to restrict the claims they make about different merchandise, and to pay $158,000 of CSPI’s authorized charges, in accordance with the settlement, which went into impact on July 30.
This text is unique to STAT+ subscribers
Unlock this text — plus in-depth evaluation, newsletters, premium occasions, and networking platform entry.
Have already got an account? Log in
Have already got an account? Log in
View All Plans
Get limitless entry to award-winning journalism and unique occasions.
Subscribe
